Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.

Literature DB >> 15714416

Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.

Nina Singh¹.

Abstract

Entities: Disease

Mesh：

Substances：
Antiviral Agents

Year: 2005 PMID： 15714416 DOI： 10.1086/427506

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

Review 1. [Pneumonias and immunosuppression].

Authors: K Dalhoff; J Marxsen; J Steinhoff
Journal: Internist (Berl) Date: 2007-05 Impact factor: 0.743

2. Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.

Authors: Corinna La Rosa; Ajit P Limaye; Aparna Krishnan; Gideon Blumstein; Jeff Longmate; Don J Diamond
Journal: Transpl Int Date: 2011-06-14 Impact factor: 3.782

3. Ganciclovir-resistant, cytomegalic interstitial lung disease in a patient with systemic lupus erythematosus.

Authors: Eduardo Finger; Helio Romaldini; David Salomão Lewi; Morton Aaron Scheinberg
Journal: Clin Rheumatol Date: 2006-12-22 Impact factor: 2.980

4. IMPACT trial results should not change current standard of care of 100 days for cytomegalovirus prophylaxis.

Authors: A C Kalil; J Sun; D F Florescu
Journal: Am J Transplant Date: 2010-11-29 Impact factor: 8.086

5. Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients.

Authors: Sameh Adel Fayek; Wana Mantipisitkul; Flavia Rasetto; Raghava Munivenkatappa; Rolf N Barth; Benjamin Philosophe
Journal: HPB (Oxford) Date: 2010-12 Impact factor: 3.647

6. Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis.

Authors: L D Snyder; R Medinas; C Chan; S Sparks; W A Davis; S M Palmer; K J Weinhold
Journal: Am J Transplant Date: 2011-01-10 Impact factor: 8.086

7. Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients.

Authors: C A Q Santos; D C Brennan; V J Fraser; M A Olsen
Journal: Transplant Proc Date: 2014-12 Impact factor: 1.066